The Committee on Dyslipidemia of Korean Pediatric and Adolescents of the Korean Society of Pediatric Endocrinology has newly developed evidence-based clinical practice guidelines for dyslipidemia in Korean chil
Medscape Nephrology is pleased to present the K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias inChronic Kidney Disease(CKD), which was published as a supplement to the April 2003 issue ofAmerican Journal of Kidney Diseases. The guidelines, available on Medscape, were developed by an...
This CPG extends and updates existing CPGs available in the literature, such as the American Association of Clinical Endocrinologists (AACE) Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Dyslipidemia and Prevention of Atherosclerosis (6 [EL 4; NE]), and complements...
15.1: SCREENING FOR NEW-ONSET DIABETES AFER TRANSPLANTATION 15.2: MANAGING NODAT OR DIABETES PRESENT AT TRANSPLANTATION 16: HYPERTENSION, DYSLIPIDEMIAS, TOBACCO USE, AND OBESITY 16.1: HYPERTENSION 16.2: DYSLIPIDEMIAS (These recommendations are based on KDOQI Dyslipidemia Guidelines and are thus not grade...
for cardiovascular syndromes and diseases in which monogenic variants inform clinical practice and guidelines for surveillance, extension to those with an elevated PRS might be warranted. A PRS for CAD with a risk equivalency to genetic variants for FH could indicate the early use of statins. This...
Among these, dyslipidemia is a key risk factor for coronary atherosclerosis, and also affects outcomes in CAD patients undergoing PCI2. Evidence-based medicine suggests that the use of statins to treat hypercholesterolemia can improve the prognosis of those with cardiovascular (CV) disease3,4. In ...
To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused on MAFLD. The guidelines cover various aspects of the disease, such as its epidemiology, diagnosis, screening, assessment, and treatment. The guidelines aim to advance...
small dense LDL and small dense HDL particles. Together these components comprise the atherogenic lipid triad. Notably the malignant nature of diabetic dyslipidaemia is not completely shown by the lipid measures used in clinical practice. The key question is what are the mechanisms behind the increase...
Kidney Disease: Improving Global Outcomes (KIDGO) has announced the publication of a new evidence-based Clinical Practice Guideline making recommendations on treatment of dyslipidemia in chronic kidney disease (CKD). KDIGO publishes clinical practice guidelines to treat CKD More results ► Medical brow...
The guidelines from the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) for the management of dyslipidemias advice to estimate the cumulative 10-years cardiovascular risk in order to determine the strategy and intensity of treatment. However, patients with documented card...